Prospective cohort study reveals persistent fibrotic-like lung changes in survivors of severe COVID-19 at six months, indicating long-term respiratory monitoring may be required.
Background: Consolidation, ground glass opacities (GGO), and thickening of interlobular septum with peripheral dispersion are common findings of COVID-19 chest CT scans, aimed to outline lasting impacts of COVID-19 in cases following their release from hospital and to pinpoint possible risk factors, such as severity of disease that may be correlated with these effects. Methods: This prospective Cohort study include 120 cases with moderate to severe COVID-19 who have been released from hospital following COVID-19 treatment. RT-PCR was performed to establish presence of SARS-CoV-2 using throat swab samples. All cases were subjected to complete history taking, clinical and laboratory examination, and imaging, including non-contrast CT chest at 0 and 6 months. Results: There was a remarkable variation between opacity score groups concerning investigations at discharge (P<0.05). Based on non-contrast CT chest results at admission, and 6 months post-discharge, the rate of GGO, consolidation, pleural effusion, reticular pattern, nodules or masses, and traction bronchiectasis findings was substantially different between the two scans (P<0.05), with reticular pattern and traction bronchiectasis being significantly higher at 6 months post discharge. Regarding outcome more patients in group 2 with Score ≥ 18 needs more days at hospital as well as invasive and non-invasive MV with significant difference. Conclusion: Six-month follow-up CT showed lung fibrotic-like changes in more than one third of patients who survived moderate and severe COVID-19 pneumonia. These changes were associated with older age, and higher initial chest CT score.
No takes yet. Share an insight, caveat, or question.
Altaher et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: